David Anderson
Deputy Director (Partnerships), Burnet Institute;
Life Sciences
Burnet Institute
Australia
Biography
Associate Professor Anderson was trained in Microbiology and Molecular Virology at the University of Melbourne and Fairfield Hospital/Burnet Institute under Professor Ian Gust and Stephen Locarnini. He received his PhD in 1989. Since that time his work has focused on understanding the structure and assembly of hepatitis viruses, and the use of this information to design better diagnostics, vaccines and antiviral therapies for control of major viral infections in humans.
Research Interest
Associate Professor Anderson has had a longstanding interest in the application of research to practical and commercial processes. This is reflected in contract and collaborative research agreements with the pharmaceutical and biotech industries since 1991.
Publications
-
A preliminary evaluation of a new GeneXpert (Gx) molecular point-of-care test for the detection of Trichomonas vaginalis. Badman SG, Causer LM, Guy R, Tabrizi SN, Francis F, Donovan B, Whiley D; TTANGO investigators (Kaldor J, Wilson D, Regan D, Wand H, Shepard M, Ward J, Fairley K, Hengel B, Tangey A, Anderson D, Natoli L) Sex Transm Infect. 2016 Aug; 92(5):350-352
-
Acceptability and feasibility of point-of-care CD4 testing on HIV continuum of care in low and middle income countries: a systematic review. Pham MD, Agius PA, Romero L, McGlynn P, Anderson D, Crowe SM, Luchters S BMC Health Serv Res. 2016 Aug; 16(1):343
-
Performance of point-of-care CD4 testing technologies in resource-constrained settings: a systematic review and meta-analysis. Pham MD, Agius PA, Romero L, McGlynn P, Anderson D, Crowe SM, Luchters S BMC Infect Dis. 2016 Oct; 16(1):592
